A detailed history of Natixis Investment Managers International transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Natixis Investment Managers International holds 118 shares of IDXX stock, worth $53,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118
Previous 179 34.08%
Holding current value
$53,260
Previous $96,000 40.63%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$468.04 - $548.53 $28,550 - $33,460
-61 Reduced 34.08%
118 $57,000
Q1 2024

May 13, 2024

SELL
$515.08 - $576.87 $30,904 - $34,612
-60 Reduced 25.1%
179 $96,000
Q3 2023

Nov 14, 2023

SELL
$432.42 - $556.67 $6,918 - $8,906
-16 Reduced 6.27%
239 $104,000
Q2 2023

Aug 11, 2023

BUY
$450.7 - $503.61 $20,732 - $23,166
46 Added 22.01%
255 $128,000
Q1 2023

May 12, 2023

SELL
$406.01 - $514.59 $43,037 - $54,546
-106 Reduced 33.65%
209 $104,000
Q3 2022

Nov 14, 2022

SELL
$325.8 - $407.78 $187,009 - $234,065
-574 Reduced 64.57%
315 $102,000
Q2 2022

Aug 12, 2022

BUY
$327.37 - $553.44 $6,220 - $10,515
19 Added 2.18%
889 $311,000
Q1 2022

May 13, 2022

BUY
$466.52 - $631.01 $308,369 - $417,097
661 Added 316.27%
870 $475,000
Q4 2021

Feb 14, 2022

BUY
$586.54 - $666.48 $122,586 - $139,294
209 New
209 $137,000
Q4 2018

Feb 14, 2019

SELL
$176.18 - $248.92 $1.82 Million - $2.57 Million
-10,309 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$218.82 - $254.46 $1.47 Million - $1.71 Million
6,735 Added 188.44%
10,309 $2.57 Million
Q2 2018

Aug 14, 2018

BUY
$185.56 - $227.9 $663,191 - $814,514
3,574 New
3,574 $779,000
Q3 2017

Nov 14, 2017

SELL
$150.32 - $166.46 $929,578 - $1.03 Million
-6,184 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
6,184
6,184 $998,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $37.6B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Natixis Investment Managers International Portfolio

Follow Natixis Investment Managers International and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.